N-terminal acetylation is ubiquitous among eukaryotic proteins and controls a myriad of biological processes. Of the N-terminal acetyltransferases (NATs) that facilitate this cotranslational modification, the heterodimeric NatA complex has the most diversity for substrate selection and modifies the majority of all N-terminally acetylated proteins. Here, we report the X-ray crystal structure of the 100-kDa holo-NatA complex from Schizosaccharomyces pombe, in the absence and presence of a bisubstrate peptide-CoA-conjugate inhibitor, as well as the structure of the uncomplexed Naa10p catalytic subunit. The NatA-Naa15p auxiliary subunit contains 13 tetratricopeptide motifs and adopts a ring-like topology that wraps around the NatA-Naa10p subunit, an interaction that alters the Naa10p active site for substrate-specific acetylation. These studies have implications for understanding the mechanistic details of other NAT complexes and how regulatory subunits modulate the activity of the broader family of protein acetyltransferases. npg
a r t i c l e s The cotranslational process of N-terminal acetylation occurs on ~85% of human proteins and ~50% of yeast proteins and mediates a wide range of biological processes including cellular apoptosis, enzyme regulation, protein localization and the N-end rule for protein degradation [1] [2] [3] [4] [5] [6] . At least three NAT complexes that perform this modification, NatA, NatB and NatC, exist as heterodimers with one unique catalytic subunit and an additional unique auxiliary subunit that both activates the enzymatic component and anchors the complex to the ribosome during translation [7] [8] [9] [10] [11] [12] [13] . Aberrant expression of the proteins that make up the NatA complex has been observed in a number of cancer-cell tissues; consequently, NAT enzymes are emerging targets for chemotherapeutic development [14] [15] [16] [17] [18] [19] [20] [21] .
The three NAT complexes are highly conserved in eukaryotes from yeast to humans and are differentiated from one another on the basis of their substrate specificities 1, 5, [22] [23] [24] . NatA, which is composed of the catalytic NAA10 subunit and the auxiliary NAA15 subunit, is the most promiscuous of all NAT enzymes; classically, it acetylates an α-amino group on nascent peptide chains with an N-terminal alanine, cysteine, glycine, serine, threonine or valine residue 1, 22, 24, 25 . Notably, recent studies demonstrate that NAA10 also exists as a monomer in cells and that it can acetylate the α-amino group of substrates with N-terminal aspartate and glutamate residues that can be generated post-translationally, but it will not acetylate traditional NatA substrates 26 . The NatB and NatC complexes acetylate the N termini of proteins with an N-terminal methionine with further specificity dependent upon the identity of the second residue 13, 23, 25, 27 . Although NATs as well as many other lysine side chain acetyltransferases require binding partners for optimal catalytic activity, no acetyltransferase has been structurally characterized in the presence of its activating partner [28] [29] [30] .
Three additional NAT enzymes, NatD-NatF, have been identified and appear to be independently active. They also have a more limited set of biologically relevant substrates and are not well characterized across eukaryotes [31] [32] [33] [34] [35] . Currently, there is no structure of a NAT complex or any of the integral subunits, and the mechanism of substrate-specific catalytic regulation by the auxiliary subunits remains uncharacterized. The only eukaryotic NAT for which structural data is available is the human NatE (NAA50) enzyme, which is independently active and has only one known biologically relevant substrate; this substrate, containing a 1-MLGP-4 N-terminal sequence, was present in an X-ray crystal structure 1, 36 .
In this study we set out to determine the molecular basis for substrate binding, acetylation specificity and mode of catalysis of the NatA complex and to determine the role of the auxiliary subunit in these activities. Toward this goal, we determined the X-ray crystal structures of the holo-NatA complex bound to acetyl CoA and a bisubstrate inhibitor, determined the structure of the Naa10p subunit bound to acetyl CoA in its uncomplexed form that preferentially acetylates a unique subset of substrates, and carried out structureguided mutational analysis to derive structure-function correlations underlying NatA acetylation.
RESULTS

Overall structure of NatA
In an attempt to prepare the NatA complex for X-ray structure determination, we overexpressed the human complex a r t i c l e s in baculovirus-infected Sf9 insect cells and the orthologous proteins from Saccharomyces cerevisiae and S. pombe in insect cells and bacteria, respectively. We found that coexpression of the S. pombe fulllength Naa15p subunit (residues 1-729) with a C-terminal truncation construct of the Naa10p subunit (residues 1-156 out of 177 total residues) produced a soluble, active heterodimeric complex that could be purified to homogeneity and crystallized for use in structural studies. Crystals of this NatA complex were formed in the presence of acetyl CoA in the P1 space group with four heterodimers in the asymmetric unit, and the structure was determined by multiwavelength anomalous diffraction with a combination of a K 2 PtBr 4 heavy atom-soaked crystal and selenomethionine-derivatized protein ( Table 1 ). The data set was collected to 3.15-Å resolution and the structure refined to R work and R free values of 22.4% and 25.9%, respectively.
The structure of the NatA complex revealed that the auxiliary Naa15p subunit is composed of 37 α-helices ranging from 8 to 32 residues in length, among which 13 conserved helical bundle tetratricopeptide repeat (TPR) motifs can be identified, which are often used in protein-protein interactions (Supplementary Fig. 1 ) 37 . Although a number of these TPR helices are involved in interactions with Naa10p, we suspect that the additional TPR motifs are important for interaction with other NatA-binding partners such as the ribosome, NatE and the HYPK chaperone 8, 38 . The Naa15p helices arrange themselves into a ring-like tertiary structure that wraps completely around the Naa10p subunit, burying a total of 3,520 Å 2 of the solvent-accessible surface area of the enzyme (Fig. 1a,b and Supplementary Video 1). This fold is reminiscent of the importin-β structure, which uses 19 tandem HEAT repeats to form a solenoid tertiary structure that surrounds its binding partner, importin-α 39 . Indeed, it appears that Naa15p stability depends on the binding of Naa10p. This is consistent with the observation that recombinant Naa15p undergoes marked degradation and precipitation when purified as a monomer.
The catalytic Naa10p subunit adopts a Gcn5-related N-acetyltransferase (GNAT) fold 40 containing a central acetyl CoA-binding region and flanking N-and C-terminal segments that are similar to the corresponding regions of NAA50. The most intimate interactions between the two proteins are made between several Naa15p helices and the N-terminal α1-loop-α2 segment of Naa10p ( Fig. 1c,d) , where the structure has relatively low B factors and is well ordered (Supplementary Fig. 2) . This region features one large hydrophobic interface between residues that span the entire length of Naa10p α2 (Leu28, Leu32, Tyr33, Ile36 and Trp38) and several residues of Naa10p α1 (Ile8 and Leu11) and residues in Naa15p α29 (Trp526, Phe533 and Phe536) and α30 (Leu549 and Trp552), as well as hydrogen bonds npg a r t i c l e s between Lys29 and Gln15 of Naa10p and Asp532 and Gln491 of Naa15p. Single point mutations in this region did not break up the complex and had only modest effects on substrate binding and catalysis ( Table 2) , probably owing to the extensiveness of the interface. A smaller hydrophobic interface is formed between Naa10p His20 and Naa15p Phe449 and Trp494 and is supplemented with a hydrogen bond between Naa10p Gln25 and Naa15p Arg448. This region of Naa15p directly stabilizes the position of the Naa10p α1 helix as well as the Naa10p α1-α2 loop and as a result is crucial for proper complex formation. This is evident from the observation that alanine point mutations at either Naa15p Arg448 or Naa15p Phe449 were able to disrupt NatA complex formation. Several additional scattered intermolecular interactions serve to supplement the Naa10p-Naa15p interface (Supplementary Fig. 3 ).
Molecular basis for Naa15p modulation of Naa10p acetylation
To explore the molecular basis for Naa15p modulation of Naa10p acetyltransferase activity, we determined the X-ray crystal structure of Naa10p of S. pombe in the absence of Naa15p, for comparison with the holo-NatA complex ( Table 1) . We determined the structure of Naa10p (residues 1-156) to 2.00-Å resolution, using a combination of singlewavelength anomalous diffraction and molecular replacement (model, NAA50) to phase data collected on a selenomethionine-derivatized Naa10p protein. An alignment of the complexed and uncomplexed forms of Naa10p revealed that the α1-loop-α2 segment assumes a substantially different conformation in the presence of Naa15p ( Fig. 2a) . Notably, this conformational change is driven by the movement of several hydrophobic residues in Naa10p α2 (Leu28, Leu32 and Ile36), which make intramolecular interactions with residues in Naa10p α1 and β3 (Ile8, Leu11, Met14, Tyr55 and Tyr57) in apo-Naa10p but shift to make alternative intermolecular interactions with helices of Naa15p in the NatA complex ( Figs. 1c and 2b) . As a result of this interaction, the C-terminal region of the α1 helix undergoes an additional helical turn, which helps to reposition the α1-α2 loop. Notably, docking of the apo-Naa10p structure into the corresponding binding pocket of Naa15p showed a clash between the Naa10p α1-loop-α2 and Naa15p Arg448 and Naa15p Phe449 of α25 ( Fig. 2c) -the same interface that we have shown to be necessary for proper complex formation ( Fig. 1d and Table 2 ). As a result of the Naa15p interaction along one side of the Naa10p α1-loop-α2 region, residues on the opposite side of this loop region appear to adopt a specific conformation that is essential for catalysis of traditional substrates (alanine, cysteine, glycine, serine, threonine or valine) (Supplementary Videos 2 and 3). Specifically, Naa10p residues Leu22 and Tyr26 shift about 5.0 Å from surface-exposed positions to buried positions in the active site, and Naa10p Glu24 moves by about 4.0 Å, substantially altering the landscape of the NatA active site ( Fig. 2d ). All of these residues are well ordered in both structures ( Supplementary Fig. 4 ). Our comparison of the complexed and uncomplexed structures suggests that the auxiliary subunit induces an allosteric change in the Naa10p active site to an extent that is required for the mechanism of catalysis by the NatA complex, and Naa10p is likely to represent an active GNAT fold. Consistent with this hypothesis, a backbone alignment of key active site elements in active Naa10p with the corresponding region in the independently active human NAA50 that selects a 1-Met-Leu-2 N-terminal sequence shows a high degree of structural conservation (r.m.s. deviation of 1.52 Å). The corresponding alignment of the complexed and uncomplexed forms of Naa10p showed less structural conservation, with an r.m.s. deviation of 2.43 Å ( Fig. 2e ).
Substrate peptide binding and NatA inhibition
To determine the molecular basis for substrate-specific peptide binding by NatA, and in particular how, unlike most other NATs, it is able to accommodate a number of nonmethionine N-terminal substrates, we synthesized a bisubstrate conjugate in which CoA is covalently linked to a biologically relevant substrate peptide fragment with the sequence 1-SASEA-5 (CoA-SASEA). We performed inhibition studies with CoA-SASEA and with a control compound, acetonyl CoA, which is a nonhydrolyzable acetyl CoA analog ( Fig. 3a) . Half-maximum inhibitory concentration (IC 50 ) determinations revealed that CoA-SASEA had an IC 50 of 1.4 ± 1.0 µM, whereas acetonyl CoA had an IC 50 of 380 ± 10 µM ( Fig. 3b) . To assess the specificity of this inhibitor toward NatA, we also calculated IC 50 values of CoA-SASEA and acetonyl CoA with NAA50, a NAT that requires a substrate N-terminal methionine residue. We found that CoA-SASEA has an IC 50 of 11 ± 2 µM, whereas acetonyl CoA has an IC 50 of 130 ± 12 µM (Fig. 3b) . With NAA50, the addition of a SASEA peptide portion was able to increase the potency of acetonyl CoA by only about tenfold, whereas with NatA this peptide addition exhibited an increase in potency of about 300-fold. The greater potency of acetonyl CoA with NAA50 over Naa10p can be explained by the stronger binding of acetyl CoA to NAA50 (K m = 27 ± 2 µM) than to Naa10p (K m = 59 ± 5 µM). The markedly higher potency of the CoA-SASEA inhibitor
α26 α25 α24 Naa10p Naa15p Figure 1 Overall structure of the NatA complex bound to acetyl CoA. (a) Naa10p (teal) and Naa15p (brown) subunits, shown in cartoon, bound to acetyl CoA (CPK coloring and stick format). Only Naa15p helices that contact Naa10p are labeled. The dashed brown line represents a disordered loop region in Naa15p. The dimensions of the complex are 107 Å × 85 Å × 70 Å. (b) A 90° rotation of the view in a. Helices that are depicted in c and d are labeled. (c) Zoom view highlighting key residues that compose the predominantly hydrophobic interface between Naa10p α1-α2 and Naa15p α29-α30. (d) Zoom view of the intersubunit interface at the C-terminal region of Naa10p α1 and the Naa15p α25-α27-α28 helices.
a r t i c l e s relative to acetonyl CoA toward NatA, along with the observed NatA specificity that the peptide portion imparts on the inhibitor, suggested that CoA-SASEA interacts with the complex in a biologically relevant conformation and can be used to understand the molecular basis for N-terminal substrate binding by NatA. We were able to cocrystallize NatA bound to CoA-SASEA and determine its X-ray crystal structure to 2.60-Å resolution, using the refined NatA-acetyl CoA structure as a search model ( Table 1 and Fig. 4a ). The structure of the bisubstrate inhibitor-bound NatA complex revealed that the N-terminal Ser1 side chain makes van der Waals interactions with Naa10p residues Leu22, Glu24 and Tyr139 (Fig. 4b) . The Naa10p Tyr139 side chain also forms a hydrogen bond with the Ser1 backbone carbonyl group, and Naa10p Tyr26 forms a hydrogen bond with the Ala2 backbone carbonyl. We observed only modest rearrangements in Naa10p upon CoA-SASEA binding as compared to acetyl CoA binding (alignment not shown).
We used in vitro activity assays to kinetically characterize the wild-type Naa10p monomer enzyme as well as wild-type NatA and a series of NatA mutants ( Table 2) . We performed these assays in the presence of a substrate peptide with an N-terminal sequence identical to that of the inhibitor, a Met1 N-terminal substrate peptide that corresponds to the NAA50 in vivo substrate and a substrate peptide with an N-terminal 1-Glu-Glu-Glu-3 sequence that matches the sequence for γ-actin, the only known NAA10 in vivo substrate. Although monomeric Naa10p is inactive with the Met1 and Ser1 N-terminal substrates, we were able to generate catalytic parameters with the Glu1 N-terminal substrate (k cat = 0.19 ± 0.02 s −1 ; K m = 1.72 ± 0.25 µM) ( Table 2 ). Whereas previous studies were able to detect acetylation of the N-terminal Glu1 substrate by the NatA complex 26 , we were unable to detect activity toward this substrate. In contrast, we were able to determine kinetic parameters for the Ser1 N-terminal substrate in the presence of a saturating amount of acetyl CoA (k cat = 3.0 ± 0.5 s −1 and K m = 340 ± 50 µM). The NatA-Naa10p L22A point mutation exhibited a >99% decrease in catalytic efficiency (k cat K m −1 ), thus suggesting that steric alterations to the N-terminal residue-binding pocket greatly hinder productive substrate binding and catalysis ( Fig. 4c and Table 2 ). Similarly, the NatA-Naa10p E24A mutant had no measurable activity. The k cat of the NatA-Naa10p E24Q mutant was reduced by 99%, and the K m was unaffected, thus emphasizing the importance of Glu24 in both substrate binding and catalysis ( Table 2 ). The NatA-Naa10p Y26A mutant resulted in a >99% decrease in catalytic efficiency, whereas we could not calculate the catalytic efficiency for the NatA-Naa10p Y139A mutant, owing to the immeasurably high K m ( Table 2) , which is probably caused by the involvement of Tyr139 in both a backbone interaction and the Ser1 side chain-binding pocket. To evaluate the active site of the uncomplexed Naa10p, we docked the bisubstrate inhibitor into the monomeric structure that is inactive toward the N-terminal Ser1 substrate. Consistent with the particular importance of Naa10p residues Leu22, Glu24, Tyr26 and Tyr139 in NatA catalysis of traditional substrates, each of these residues is not in a position for productive substrate binding and catalysis in uncomplexed Naa10p, with the exception of Tyr139 (Fig. 4d) .
Although all of the important catalytic residues noted above for NatA catalysis of the Ser1 N-terminal substrate appear to be out of place for catalysis by the Naa10p monomer, the subunit is able to catalyze acetylation of the Glu1 N-terminal substrate, thus suggesting that the acetylation reaction by monomeric Naa10p is catalyzed through an alternate mechanism to that of the NatA complex. To investigate the possibility that the Glu1 N-terminal substrate does not require npg a r t i c l e s the Glu24 catalytic residue for acetylation, we performed an assay using this substrate and the NatA E24A mutant. This mutant, which we found will not acetylate the N-terminal Ser1 or Met1 N-terminal substrates used in this study, is able to acetylate the Glu1 N-terminal substrate with a rate of 0.65 ± 0.08 s −1 , which is ~22% of the rate of the wild-type NatA complex with its cognate Ser1 N-terminal substrate peptide ( Table 2) . We suspect that the more open N-terminal residue-binding pocket is able to accommodate an N-terminal Glu1 substrate peptide and that the carboxylic-acid group of the glutamate side chain occupies a position similar to the corresponding group in the wild-type NatA Glu24 side chain; consequently, it seems to be able to play an equivalent part in catalysis. The recovery of activity for this substrate-mutant combination further supports the importance of the Glu24 carboxylic-acid moiety in the NatA catalytic mechanism.
To determine the molecular basis for the inability of NatA to acetylate N-terminal methionine and glutamate residues, we modeled an N-terminal glutamate residue and docked the human NAA50 substrate into the active Naa10p site (Fig. 4e) . This superposition revealed that Naa10p Glu24 would clash with the substrate peptide glutamate and methionine residues, thus suggesting that Naa10p Glu24 is particularly important for excluding these N-terminal substrates. This is consistent with the importance of the corresponding human Naa50 Val29 residue for N-terminal methionine recognition and acetylation 36 . We also modeled substrate N-terminal threonine and valine residues, the most bulky NatA substrates, into the active site to show that these residues' side chains, similarly to serine's, can also be accommodated without steric clash in the wild-type NatA substrate-binding pocket (Fig. 4e) .
Catalysis by NatA
Previous structural and kinetic studies on human NAA50 support a dual base mechanism in which NAA50 Tyr73 and His112, located in the central core region and C-terminal segment of the catalytic domain, contribute to proton abstraction from the substrate α-amino group to facilitate the acetylation reaction 36 . An active site alignment of these enzymes shows that Naa10p also has two potential general bases in corresponding positions, Naa10p His72 and His111 (Fig. 5a) . Figure 2 Structure of the Naa10p monomer bound to acetyl CoA. (a) Structural alignment of the uncomplexed Naa10p monomer (silver cartoon) bound to acetyl CoA (gray stick format) with the active Naa10p from the NatA structure (teal cartoon). (b) Zoom view of the surface-exposed Naa10p α1-α2 region from the alignment shown in a that highlights residues in these two helices that undergo a conformational shift upon Naa15p association. (c) Alignment from a, docked into the Naa15p subunit. The stretch of the α1-α2 loop in the Naa10p monomer that clashes with Naa15p is highlighted with a dashed box, and a zoom view of this region is also shown. Secondarystructural elements in the zoom view are shown in cartoon format and have been labeled. Key residue side chains are shown in stick format and have been labeled. npg a r t i c l e s results arguing against the importance of these residues in catalysis by Naa10p ( Table 2) . Notably, NAA50 also has an active site water molecule that probably has a catalytic role. This water molecule is not observed in the Naa10p active site and further supports the idea that NatA uses a different catalytic strategy 36 .
The NatA structures reveal that Glu24, located in the loop between the α1 and α2 helices in the N-terminal segment of the Naa10p catalytic domain, is in proximity to the N-terminal residue and could be playing a part in catalysis (Fig. 5a) . This is consistent with our observation that the E24Q mutant shows a 99% reduction in k cat and has a negligible effect on K m , thus suggesting that the carboxylicacid moiety is essential for catalysis but is not required for substrate binding ( Table 2 ). In both Gcn5 and ESA1, mutation of the general base glutamate to a glutamine also results in a decrease in k cat by ~2 orders of magnitude, and this supports the possibility that Naa10p Glu24 of NatA could be acting as a general base in the NatA acetylation reaction 41, 42 , whereby the buried glutamate residue causes an increase in side chain pK a that allows it to directly deprotonate the AANAT (His120/His122) npg a r t i c l e s substrate amino group. Alternatively, the glutamate residue could act through an electrostatic mechanism, causing an induced dipole on the α-amino group that would increase the nucleophilicity of the substrate, or it could be involved in proper positioning of the α-amino group within the active site. Although NatA-Naa10p Glu24 functions as an essential catalytic residue, it is also possible that NatA-Naa10p Tyr139, located in the C-terminal segment of the Naa10p catalytic domain, also contributes to catalysis, owing to its location in the active site and the dramatic effect on catalysis observed for the NatA-Naa10p Y139A mutant. Notably, NatA-Naa10p Arg113, also in this C-terminal segment, forms an ionic interaction with Glu24. An observed 94% reduction in catalytic efficiency for the Naa10p R113A mutant suggests that this residue may also be important for proper positioning of the Naa10p Glu24, by altering the pK a of the Glu24 side chain, or it may have some other function in the NatA catalytic mechanism or substrate binding. A comparison of the catalytic efficiencies of potential key catalytic residues is shown (Fig. 4c) . A sequence alignment of the Naa10p catalytic subunits from a diverse group of eukaryotic species reveals that all of the α1-α2 loop residues, as well as Arg113 and Tyr139, are strictly conserved, and this reinforces the importance of these residues in catalysis ( Fig. 5b) .
To further dissect the reaction mechanism, we also calculated K i values of the CoA-SASEA inhibitor as well as its mode of inhibition toward both acetyl CoA and the substrate peptide. Our results (Supplementary Fig. 5 ) reveal that CoA-SASEA is a competitive inhibitor as compared to acetyl CoA (K i = 1.1 ± 0.1 µM) and a noncompetitive inhibitor as compared to the substrate peptide (K i = 8.9 ± 0.1 µM). This pattern of inhibition supports an ordered BiBi model for catalysis, with acetyl CoA binding occurring before substrate peptide binding. This type of mechanism was also recently reported for NAA50 in a study that used NMR experiments to show that acetyl CoA binding induces rearrangements in the peptidebinding pocket and that the peptide has a far greater affinity toward the NAA50-acetyl CoA complex over the apoenzyme 43 .
DISCUSSION
The data presented here reveal that Naa15p allosterically reconfigures the Naa10p active site for sequence-specific N-terminal acetylation. Specifically, this study highlights a unique mechanism in which NatA substrate binding specificity is coupled to the catalytic strategy. This finding is supported by evidence that an N-terminal residue of an incompatible substrate, such as a methionine, would have to displace Glu24, an essential catalytic residue, for binding to occur (Fig. 4e) . Furthermore, upon modeling all bulky, β-branched NatA cognate substrate N-terminal residues into the binding pocket, we find that none of them clash with the Glu24 residue, and this further supports the importance of this residue and its role in substrate-specific acetylation (Fig. 4e) . We also note that in the absence of Glu24, the Glu1 N-terminal substrate can undergo acetylation, probably because the side chain carboxylic-acid moiety is able to functionally replace the corresponding group on the Glu24 side chain. This could also explain the activity observed for the Naa10p monomer in the presence of this substrate 26 .
Comparison of the Naa10p active site with the corresponding region of NAA50 and other protein or small molecule acetyltransferases shows prominent differences that appear to underlie the requirement of Naa15p binding for Naa10p acetyltransferase activity toward conventional substrates. In particular, three catalytically essential Naa10p residues in the α1-α2 loop N terminal to the catalytic core region-Leu22, Glu24 and Tyr26-are not correctly positioned for catalysis in the uncomplexed form of the enzyme. Notably, in the context of the NatA complex, the Leu22 and Tyr26 side chains shift from surface-exposed positions into the active site while the Glu24 side chain is repositioned by ~5 Å to facilitate the observed coupling of substrate binding specificity and catalysis. These changes in the Naa10p conformation are essential for productive catalysis of traditional substrates. In contrast, the independently active NAA50 and other acetyltransferases have their key catalytic residues located on the opposite side of the substrate, either within the central core region or the segment C terminal to the catalytic core region (Fig. 5c ). It appears that Naa10p's key residues for catalysis are on the opposite side of the substrate, relative to those of NAA50 and the other acetyltransferases, to allow for catalytic regulation through Naa15p binding.
A sequence alignment of the Naa10p catalytic subunits from a diverse group of eukaryotic species reveals that all of the α1-α2 loop residues, as well as Arg113 and Tyr139, are strictly conserved, and this reinforces the importance of these residues in catalysis (Fig. 5b) . In addition, on the basis of our findings of Naa15p regulation of Naa10p activity, we propose that the catalytic subunits of the NatB and NatC NAT complexes are modulated for acetylation in similar ways by their auxiliary subunits. This hypothesis is consistent with the strict conservation of the Naa10p Leu22, Glu24 and Tyr26 residues across catalytic subunits of each of these NAT complexes (Fig. 5d) , and it also reinforces the importance of this loop for enzymatic activity of NAT enzymes. However, NatB and NatC both acetylate methioninecontaining N-terminal substrates, so these complexes probably use other strategies to accommodate their respective substrates. Many protein lysine side chain acetyltransferases, including HAT1 (ref. 30 ), HBO1 (ref. 29 ) and Sas2 (ref. 28) , also require auxiliary subunits for activated acetylation, and it is of strong interest to determine whether they also share similar strategies for catalytic regulation with heterodimeric NAT proteins.
The unique features of the NatA complex could be exploited for the development of NatA-specific inhibitors. Indeed, to our knowledge, the CoA-SASEA NatA inhibitor that we have prepared is the most potent NAT inhibitor that has been reported to date. This inhibitor may serve as a suitable probe for NatA inhibition in vitro, and although peptide-based inhibitors are generally not suitable molecules for cell-based studies, owing to their poor ability to penetrate cell membranes, the CoA-SASEA inhibitor may nonetheless serve as a starting point for the development of small-molecule mimics with better pharmacological properties. Furthermore, our inhibition studies suggest that inhibitors targeting the peptide-binding pocket have the potential to specifically inhibit NatA relative to other NATs, whereas acetyl CoA analogs will probably exhibit more promiscuous inhibition patterns. Given the observation that NatA subunits are often overexpressed in several different cancer tissues, NatA inhibitors may have therapeutic application 14, 18 .
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The coordinates of the structures have been deposited in the Protein Data Bank under accession codes 4KVX (Naa10p-acetyl CoA), 4KVO (Naa10p-Naa15p-acetyl CoA) and 4KVM (Naa10p-Naa15p-bisubstrate inhibitor).
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Naa10p expression and purification. The full-length Naa10p gene (encoding residues 1-177) was cloned out of the S. pombe genome (ATCC), and several C-terminal truncation constructs were engineered into a modified pETDUET vector containing a TEV protease-cleavable His 6 tag. All constructs were transformed into Rosetta (DE3)pLysS competent E. coli cells, which were grown to an OD 600 of 0.7 and induced with 0.5 mM IPTG at 16 °C for ~16 h. Cells were isolated by centrifugation and lysed by sonication in a buffer containing 25 mM Tris, pH 8.0, 500 mM NaCl, 10 mM β-ME and a complete, EDTA-free protease inhibitor tablet (Roche). The solution was isolated and passed over Ni resin (Thermo Scientific), which was subsequently washed with >20 column volumes of lysis buffer supplemented with 25 mM imidazole. The protein was eluted in the same buffer with an imidazole gradient (25-500 mM imidazole), and TEV protease was added to fractions containing the target protein for the duration of a 14-h dialysis into lysis buffer. The solution was passed through an additional nickel column to remove TEV protease as well as any uncut Naa10p. The resin was then washed with approximately seven column volumes of lysis buffer supplemented with 25 mM imidazole, which was pooled with the initial flow through. This solution was dialyzed into a buffer containing 25 mM sodium citrate monobasic, pH 5.5, 100 mM NaCl and 2 mM DTT and loaded onto a 5-mL HiTrap SP ion-exchange column (GE Healthcare). The protein was eluted in the same buffer with a salt gradient (100-750 mM NaCl). Peak fractions were concentrated to 8.0 mg mL −1 (10-kDa concentrator; Amicon Ultra, Millipore), as measured by UV 280 absorbance (extinction coefficient = 18,000), for crystallization trials. The selenomethionine derivative was prepared by expression of Naa10p (residues 1-156) in minimal medium (Molecular Dimensions) containing 50 µg L −1 of selenomethionine (Sigma), which was purified with the scheme described above.
Naa10p-Naa15p complex expression and purification. The full-length Naa15p gene (encoding residues 1-729) was cloned out of the S. pombe genome and engineered into MCSI of a modified pETDUET vector containing a TEV proteasecleavable His 6 tag. DNA encoding residues 1-156 of Naa10p was engineered into MCSII of the corresponding vector. Cells were grown, and the binary protein complex was prepared essentially as described for Naa10p, except that the first of two peaks that eluted from the HiTrap SP ion-exchange column was concentrated to 1 mL, and loaded onto an s200prep gel-filtration column (GE Healthcare) in a buffer containing 25 mM HEPES, pH 7.0, 200 mM NaCl and 1 mM TCEP. This protein was concentrated to 15 mg mL −1 , as measured by UV 280 (extinction coefficient = 100,000) for crystallization trials. The selenomethionine-labeled complex was obtained as described above. Point-mutation proteins were generated with the Stratagene QuikChange protocol, and protein containing point mutations was expressed and purified with the protocols described above 44 .
Naa10p crystallization and structure determination. Naa10p at a concentration of 8 mg mL −1 was mixed with acetyl CoA at a 1:3 molar ratio. Initial crystallization hits were obtained from an Naa10p construct containing residues 1-161 (Naa10p (residues 1-161)) with hanging-drop vapor diffusion at 20 °C with a well solution containing 16% PEG 8000 (Hampton Research), 10% ethylene glycol and 0.1M HEPES, pH 7.5, and yielded poor diffraction. These crystals were used to seed entire grid screens with Naa10p (residues 1-156), which did not crystallize in the absence of the seed crystals. Large crystals of Naa10p (residues 1-156) were obtained from this screen in a 1:1 mixture of protein and well solution (14% PEG 3350 and 0.1 M bis-Tris, pH 6.5) with hanging-drop vapor diffusion at 20 °C. An additive screen (Hampton Research) revealed that these crystals could be reproduced in the absence of seed crystals when 10% glycerol was present as an additive in the crystallization drop. Final crystallization conditions of the Naa10p protein (construct 1-156) were optimized and included a drop with a 2.5:0.5:2.0 ratio of protein (8 mg mL −1 )/glycerol (50%)/well solution, mixed in that order. Selenomethionine crystals of this construct were obtained with identical conditions with a lower protein concentration (6.5 mg mL −1 ). Diffraction-quality crystals required 1-3 days to grow to maximum dimensions.
Data sets were collected at beamline X29A at the National Synchrotron Light Source (Brookhaven National Laboratory) and processed with HKL2000 (ref. 45) . Initial molecular replacement trials with Phaser were performed with several truncated variants of the hNAA50 structure (PDB 3TFY) as a model but were unable to provide electron density maps suitable for model building 46 . A data set was then collected on the selenomethionine-labeled protein at the selenium peak wavelength (0.9795 Å), but selenium sites could not be identified with singlewavelength anomalous diffraction (SAD) or single isomorphous replacement with anomalous scattering (SIRAS). We located the selenium sites by performing molecular replacement (as described above) on the selenomethionine-derivative data set, contouring the output electron density map to 3.0σ and placing selenium atoms at the resulting peaks in Coot 47 . These sites were input into Phaser along with the hNAA50 model, and an MR-SAD approach yielded high-quality electron density maps. Initial model building was carried out with ARP/wARP, and refinement was carried out with Phenix.refine (experimental phases excluded throughout refinement) while applying two-fold NCS 48, 49 . TLS was used in later stages of refinement (TLS groups defined with the open-access server) 50, 51 . Manual refinement and additional model building were performed with Coot. The selenomethionine-containing crystals diffracted to a higher resolution (2.00 Å) than did the wild-type crystals (2.60 Å), and so the structure used in all analyses was that of the SeMet-derivatized protein. The final model was checked for errors with a composite omit map generated by AutoBuild in the Phenix suite 49 .
Naa10p-Naa15p crystallization and structure determination. The Naa10p (residues 1-156)-Naa15p (full-length) complex was concentrated to 12 mg mL −1 , mixed with 3× cofactor (acetyl CoA or bisubstrate inhibitor) and allowed to stand for 12-15 h at 4 °C. The initial crystallization hit was obtained with hanging-drop vapor diffusion at 20 °C in a well solution containing 10% PEG 4000, 10% isopropanol and 0.1 M HEPES, pH 7.0 (all reagents from Qiagen). The best crystals were obtained by mixing protein/well at a 2.0-µL/2.0-µL ratio and grew to maximum dimensions in 7-10 d. These crystals were transferred into mother liquor supplemented with ethylene glycol in 5% increments (15%, 20% and 25%) for 1 min at each concentration and were finally flash-frozen in liquid nitrogen. The selenomethionine-labeled protein required that the protein buffer be supplemented with 1 mM reduced l-glutathione and 1 mM oxidized l-glutathione for crystallization to occur in conditions identical to those described for the native Naa10p-Naa15p complex. The crystals were cryoprotected in the stepwise manner described above. To derivatize native crystals with Pt(II), the crystals were transferred into mother liquor supplemented with 1 mM K 2 PtBr 4 for 20 min before cryoprotection with the method described for the native Naa10p-Naa15p complex.
Data sets were collected at beamlines X25 and X29A at the National Synchrotron Light Source (Brookhaven National Laboratory) and processed with HKL2000. For phasing, a total of 1,000 degrees (1° per frame) were collected on a single derivatized crystal (500 frames at the peak wavelength and 500 frames at the inflection wavelength) to reach desirable completeness and redundancy in the P1 space group, and data sets were processed to 3.50-Å resolution. The twowavelength MAD data were used by the Hybrid Substructure Search in Phenix to identify a total of eight heavy-atom sites in the asymmetric unit, and initial phases were obtained with SOLVE 49, 52 . Density modification was performed in Resolve by application of four-fold NCS (corresponding to each heterodimer) and with histogram matching and solvent flattening 53 . Initially, the Naa15p helices were built as polyalanine chains, and the Naa10p molecules were manually placed into the density-modified map with Coot. The resulting structure was used as a molecular replacement model for the selenomethionine-derivative data set that was collected at the selenium peak wavelength and processed to 3.35-Å resolution. A total of 80 selenium sites were located manually in the asymmetric unit by contouring of the map to 3.0σ and placement of selenium atoms in the peaks in Coot. These sites were used to place methionine residues in Naa15p, and manual model building was completed in Coot with the methionine residues as a guide. The final structure was used as a molecular replacement model for the high-resolution data sets (500° of data each) of the Naa10p-Naa15p-acetyl CoA (3.10-Å resolution) and the Naa10p-Naa15p-bisubstrate inhibitor (2.60-Å resolution) complexes. Refinement of the binary-complex structures was carried out in Phenix, and four-fold NCS restraints were applied to two separate groups: the full-length Naa10p molecules, and residues 100-731 of Naa15p. The positioning of the first five N-terminal helices in the Naa15p subunit is slightly different in each heterodimer, so NCS could not be applied to this region. TLS was also used in later stages of refinement (TLS groups defined with the open-access server). The backbone for the α20-α21 loop from residues 356-377 can be traced; however, it is largely disordered (average B factor = 196 Å 2 ), as it probably samples numerous conformations in the crystal. No density was observed for a loop from npg
